{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0017994/ORPHA:329249","label":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","mondoId":"MONDO:0017994","onsetQualifier":null,"recordKeys":["27bb49810e3055028c580d14d8b45ece96e78ed36293106bab1f1f193c53d516","2802d95eb1b55623b738ef6b7cb56080fc1d38ad0c9f56c134d9af923a46ff4e","41e92a8a78344e2d3ddde0c2060e34de17723886b7ae21d6310092c481eb4166","4aa2a50910eb310ca3c7de06d94d3b157f38e5692c8c977ed1cf9aa82982fbb1","66bc67bb20f4d94093fbc34b3a3fea0e6ec0cf753fcf9d47b366729640fda1d8","907e0f7510597fe1e507e07a215240fb908fb12aaccf1c7d9ee2d5497e7eb178","b2a9bf11c8c32890562b97ad999be588b28355eb702545ddd4dd062679ceaa98","b4d6709368588b3b87d241d96776870666114bfff15b3cb71ab01dc0966749ff","bee976e55e220e0d8e7e829d5cf0733c708a0ef792c7d4385698af0c1a7374d5","e01f7c385a7bdc091fa73fc00c59f6585255e55aa90872b23ce5c166a80eddbc","e716482dc0d2063789a9465096e0cc37d036021a57405188af6022f1f2ed9ab8"],"recordQualifiers":{},"scopeLabel":"ORPHA:329249","sourceIds":["ORPHA:329249"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0017994/ORPHA:329249"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"omim":0,"orphanet":11,"published":0}},"features":[{"hpoId":"HP:0000718","label":"Aggressive behavior","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language","primary":false},{"hpoId":"HP:0002910","label":"Elevated circulating hepatic transaminase concentration","primary":false},{"hpoId":"HP:0003074","label":"Hyperglycemia","primary":false},{"hpoId":"HP:0000842","label":"Hyperinsulinemia","primary":false},{"hpoId":"HP:0003077","label":"Hyperlipidemia","primary":false},{"hpoId":"HP:0008763","label":"No social interaction","primary":false},{"hpoId":"HP:0001513","label":"Obesity","primary":false},{"hpoId":"HP:0002591","label":"Polyphagia","primary":false},{"hpoId":"HP:0012760","label":"Reduced social responsiveness","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0017994","records":[{"frequencyKind":"reported","key":"27bb49810e3055028c580d14d8b45ece96e78ed36293106bab1f1f193c53d516","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003074","is_excluded":true,"label":"Hyperglycemia","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"2802d95eb1b55623b738ef6b7cb56080fc1d38ad0c9f56c134d9af923a46ff4e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003077","is_excluded":true,"label":"Hyperlipidemia","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"41e92a8a78344e2d3ddde0c2060e34de17723886b7ae21d6310092c481eb4166","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4aa2a50910eb310ca3c7de06d94d3b157f38e5692c8c977ed1cf9aa82982fbb1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002591","is_excluded":false,"label":"Polyphagia","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"66bc67bb20f4d94093fbc34b3a3fea0e6ec0cf753fcf9d47b366729640fda1d8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"907e0f7510597fe1e507e07a215240fb908fb12aaccf1c7d9ee2d5497e7eb178","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000842","is_excluded":false,"label":"Hyperinsulinemia","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b2a9bf11c8c32890562b97ad999be588b28355eb702545ddd4dd062679ceaa98","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002910","is_excluded":true,"label":"Elevated circulating hepatic transaminase concentration","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b4d6709368588b3b87d241d96776870666114bfff15b3cb71ab01dc0966749ff","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001513","is_excluded":false,"label":"Obesity","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bee976e55e220e0d8e7e829d5cf0733c708a0ef792c7d4385698af0c1a7374d5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000718","is_excluded":false,"label":"Aggressive behavior","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e01f7c385a7bdc091fa73fc00c59f6585255e55aa90872b23ce5c166a80eddbc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012760","is_excluded":false,"label":"Reduced social responsiveness","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e716482dc0d2063789a9465096e0cc37d036021a57405188af6022f1f2ed9ab8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:329249","disease_name":"Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008763","is_excluded":false,"label":"No social interaction","onset_id":null,"reference":"ORPHA:329249","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"severe-early-onset-obesity-insulin-resistance-syndrome-due-to-sh2b1-deficiency","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency"},"schemaVersion":1}